D.E. Shaw & Co’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24M | Buy |
|
|||||
|
2025
Q1 | $22.4M | Buy |
|
|||||
|
2024
Q4 | $24.9M | Buy |
|
|||||
|
2024
Q3 | $31.5M | Buy |
|
|||||
|
2024
Q2 | $27.6M | Sell |
|
|||||
|
2024
Q1 | $27M | Sell |
|
|||||
|
2023
Q4 | $34.5M | Sell |
|
|||||
|
2023
Q3 | $34.9M | Buy |
|
|||||
|
2023
Q2 | $47M | Buy |
|
|||||
|
2023
Q1 | $46M | Buy |
|
|||||
|
2022
Q4 | $26.9M | Buy |
|
|||||
|
2022
Q3 | $33.5M | Sell |
|
|||||
|
2022
Q2 | $37.1M | Buy |
|
|||||
|
2022
Q1 | $47.5M | Sell |
|
|||||
|
2021
Q4 | $52.6M | Sell |
|
|||||
|
2021
Q3 | $64.9M | Sell |
|
|||||
|
2021
Q2 | $68.6M | Sell |
|
|||||
|
2021
Q1 | $81M | Sell |
|
|||||
|
2020
Q4 | $63.6M | Sell |
|
|||||
|
2020
Q3 | $44.5M | Buy |
|
|||||
|
2020
Q2 | $37.3M | Buy |
|
|||||
|
2020
Q1 | $38.4M | Sell |
|
|||||
|
2019
Q4 | $78.1M | Buy |
|
|||||
|
2019
Q3 | $71.7M | Sell |
|
|||||
|
2019
Q2 | $92.3M | Sell |
|
|||||
|
2019
Q1 | $128M | Sell |
|
|||||
|
2018
Q4 | $114M | Buy |
|
|||||
|
2018
Q3 | $179M | Sell |
|
|||||
|
2018
Q2 | $151M | Sell |
|
|||||
|
2018
Q1 | $124M | Sell |
|
|||||
|
2017
Q4 | $163M | Sell |
|
|||||
|
2017
Q3 | $176M | Buy |
|
|||||
|
2017
Q2 | $124M | Buy |
|
|||||
|
2017
Q1 | $80.6M | Buy |
|
|||||
|
2016
Q4 | $46.2M | Buy |
|
|||||
|
2016
Q3 | $45.8M | Sell |
|
|||||
|
2016
Q2 | $88.9M | Sell |
|
|||||
|
2016
Q1 | $110M | Buy |
|
|||||
|
2015
Q4 | $107M | Buy |
|
|||||
|
2015
Q3 | $77.9M | Buy |
|
|||||
|
2015
Q2 | $54.1M | Buy |
|
|||||
|
2015
Q1 | $51.4M | Sell |
|
|||||
|
2014
Q4 | $51.8M | Buy |
|
|||||
|
2014
Q3 | $58.2M | Buy |
|
|||||
|
2014
Q2 | $31.1M | Buy |
|
|||||
|
2014
Q1 | $2.65M | Sell |
|
|||||
|
2013
Q4 | $6.75M | Buy |
|
|||||
|
2013
Q3 | $5.56M | Sell |
|
|||||
|
2013
Q2 | $31.8M | Buy |
|